Insmed Inc’s recent filing unveils that its Chief People Strategy Officer Schaeffer Orlov S Nicole unloaded Company’s shares for reported $11.13 million on Sep 12 ’25. In the deal valued at $145.45 per share,76,520 shares were sold. As a result of this transaction, Schaeffer Orlov S Nicole now holds 36,461 shares worth roughly $5.29 million.
Then, SHAROKY MELVIN MD sold 10,000 shares, generating $1,453,900 in total proceeds. Upon selling the shares at $145.39, the Director now owns 262,675 shares.
Before that, Schaeffer Orlov S Nicole bought 76,520 shares. Insmed Inc shares valued at $11,127,662 were divested by the Officer at a price of $145.42 per share.
William Blair initiated its Insmed Inc [INSM] rating to an Outperform in a research note published recently. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in mid August from “an Overweight” to “an Equal-weight”. Jefferies began covering INSM with “Buy” recommendation on May 13, 2025. RBC Capital Mkts started covering the stock on February 25, 2025. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Monday, Insmed Inc [NASDAQ:INSM] saw its stock jump 0.19% to $145.03. Over the last five days, the stock has gained 1.32%. Insmed Inc shares have risen nearly 99.03% since the year began. Nevertheless, the stocks have risen 110.07% over the past one year. While a 52-week high of $149.08 was reached on 09/09/25, a 52-week low of $60.40 was recorded on 04/09/25.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 143.80, which if violated will result in even more drops to 142.58. On the upside, there is a resistance level at 146.48. A further resistance level may holdings at 147.94.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-08-29, growing by 1.03 million shares to a total of 10.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 9.54 million shares. There was a rise of 9.71%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 23, 2024 when Truist began covering the stock and recommended ‘”a Buy”‘ rating along with a $48 price target.
